Association of COVID-19 coinfection with increased mortality among patients with Pseudomonas aeruginosa bloodstream infection in the Veterans Health Administration system
Abstract Objective: Pseudomonas aeruginosa bloodstream infection (PA-BSI) and COVID-19 are independently associated with high mortality. We sought to demonstrate the impact of COVID-19 coinfection on patients with PA-BSI. Design: Retrospective cohort study. Setting: Veterans Health Administrat...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Cambridge University Press
2023-01-01
|
Series: | Antimicrobial Stewardship & Healthcare Epidemiology |
Online Access: | https://www.cambridge.org/core/product/identifier/S2732494X23004552/type/journal_article |
_version_ | 1827583925996748800 |
---|---|
author | Leila S. Hojat Brigid M. Wilson Federico Perez Maria F. Mojica Mendel E. Singer Robert A. Bonomo Lauren H. Epstein |
author_facet | Leila S. Hojat Brigid M. Wilson Federico Perez Maria F. Mojica Mendel E. Singer Robert A. Bonomo Lauren H. Epstein |
author_sort | Leila S. Hojat |
collection | DOAJ |
description |
Abstract
Objective:
Pseudomonas aeruginosa bloodstream infection (PA-BSI) and COVID-19 are independently associated with high mortality. We sought to demonstrate the impact of COVID-19 coinfection on patients with PA-BSI.
Design:
Retrospective cohort study.
Setting:
Veterans Health Administration.
Patients:
Hospitalized patients with PA-BSI in pre-COVID-19 (January 2009 to December 2019) and COVID-19 (January 2020 to June 2022) periods. Patients in the COVID-19 period were further stratified by the presence or absence of concomitant COVID-19 infection.
Methods:
We characterized trends in resistance, treatment, and mortality over the study period. Multivariable logistic regression and modified Poisson analyses were used to determine the association between COVID-19 and mortality among patients with PA-BSI. Additional predictors included demographics, comorbidities, disease severity, antimicrobial susceptibility, and treatment.
Results:
A total of 6,714 patients with PA-BSI were identified. Throughout the study period, PA resistance rates decreased. Mortality decreased during the pre-COVID-19 period and increased during the COVID-19 period. Mortality was not significantly different between pre-COVID-19 (24.5%, 95% confidence interval [CI] 23.3–28.6) and COVID-19 period/COVID-negative (26.0%, 95% CI 23.5–28.6) patients, but it was significantly higher in COVID-19 period/COVID-positive patients (47.2%, 35.3–59.3). In the modified Poisson analysis, COVID-19 coinfection was associated with higher mortality (relative risk 1.44, 95% CI 1.01–2.06). Higher Charlson Comorbidity Index, higher modified Acute Physiology and Chronic Health Evaluation score, and no targeted PA-BSI treatment within 48 h were also predictors of higher mortality.
Conclusions:
Higher mortality was observed in patients with COVID-19 coinfection among patients with PA-BSI. Future studies should explore this relationship in other settings and investigate potential SARS-CoV-2 and PA synergy.
|
first_indexed | 2024-03-08T23:21:10Z |
format | Article |
id | doaj.art-bc4c806df9f649f290672a169257ee5d |
institution | Directory Open Access Journal |
issn | 2732-494X |
language | English |
last_indexed | 2024-03-08T23:21:10Z |
publishDate | 2023-01-01 |
publisher | Cambridge University Press |
record_format | Article |
series | Antimicrobial Stewardship & Healthcare Epidemiology |
spelling | doaj.art-bc4c806df9f649f290672a169257ee5d2023-12-15T06:28:34ZengCambridge University PressAntimicrobial Stewardship & Healthcare Epidemiology2732-494X2023-01-01310.1017/ash.2023.455Association of COVID-19 coinfection with increased mortality among patients with Pseudomonas aeruginosa bloodstream infection in the Veterans Health Administration systemLeila S. Hojat0https://orcid.org/0000-0003-4364-8141Brigid M. Wilson1https://orcid.org/0000-0003-2966-2940Federico Perez2Maria F. Mojica3https://orcid.org/0000-0002-1380-9824Mendel E. Singer4https://orcid.org/0000-0002-3331-3340Robert A. Bonomo5Lauren H. Epstein6Department of Medicine, Division of Infectious Diseases, Case Western Reserve University, Cleveland, OH, USA Division of Infectious Diseases and HIV Medicine, University Hospitals Cleveland Medical Center, Cleveland, OH, USADepartment of Medicine, Division of Infectious Diseases, Case Western Reserve University, Cleveland, OH, USA Geriatric Research Education and Clinical Center (GRECC), the VA Northeast Ohio Healthcare System, Cleveland, OH, USADepartment of Medicine, Division of Infectious Diseases, Case Western Reserve University, Cleveland, OH, USA Geriatric Research Education and Clinical Center (GRECC), the VA Northeast Ohio Healthcare System, Cleveland, OH, USA Case Western Reserve University, Cleveland VAMC Center for Antimicrobial Resistance and Epidemiology (Case VA CARES), Cleveland, OH, USACase Western Reserve University, Cleveland VAMC Center for Antimicrobial Resistance and Epidemiology (Case VA CARES), Cleveland, OH, USA Research Service, VA Northeast Ohio Healthcare System, Cleveland, OH, USA Grupo de Resistencia Antimicrobiana y Epidemiología Hospitalaria, Universidad El Bosque, Bogotá, Colombia Departments of Pathology, Pharmacology, Molecular Biology and Microbiology, Biochemistry, and Proteomics and Bioinformatics, Case Western Reserve University School of Medicine, Cleveland, OH, USADepartment of Population and Quantitative Health Sciences, Case Western Reserve University, Cleveland, OH, USADepartment of Medicine, Division of Infectious Diseases, Case Western Reserve University, Cleveland, OH, USA Geriatric Research Education and Clinical Center (GRECC), the VA Northeast Ohio Healthcare System, Cleveland, OH, USA Case Western Reserve University, Cleveland VAMC Center for Antimicrobial Resistance and Epidemiology (Case VA CARES), Cleveland, OH, USA Research Service, VA Northeast Ohio Healthcare System, Cleveland, OH, USA Departments of Pathology, Pharmacology, Molecular Biology and Microbiology, Biochemistry, and Proteomics and Bioinformatics, Case Western Reserve University School of Medicine, Cleveland, OH, USAInfectious Diseases, US Department of Veterans Affairs Medical Center, Decatur, GA, USA Abstract Objective: Pseudomonas aeruginosa bloodstream infection (PA-BSI) and COVID-19 are independently associated with high mortality. We sought to demonstrate the impact of COVID-19 coinfection on patients with PA-BSI. Design: Retrospective cohort study. Setting: Veterans Health Administration. Patients: Hospitalized patients with PA-BSI in pre-COVID-19 (January 2009 to December 2019) and COVID-19 (January 2020 to June 2022) periods. Patients in the COVID-19 period were further stratified by the presence or absence of concomitant COVID-19 infection. Methods: We characterized trends in resistance, treatment, and mortality over the study period. Multivariable logistic regression and modified Poisson analyses were used to determine the association between COVID-19 and mortality among patients with PA-BSI. Additional predictors included demographics, comorbidities, disease severity, antimicrobial susceptibility, and treatment. Results: A total of 6,714 patients with PA-BSI were identified. Throughout the study period, PA resistance rates decreased. Mortality decreased during the pre-COVID-19 period and increased during the COVID-19 period. Mortality was not significantly different between pre-COVID-19 (24.5%, 95% confidence interval [CI] 23.3–28.6) and COVID-19 period/COVID-negative (26.0%, 95% CI 23.5–28.6) patients, but it was significantly higher in COVID-19 period/COVID-positive patients (47.2%, 35.3–59.3). In the modified Poisson analysis, COVID-19 coinfection was associated with higher mortality (relative risk 1.44, 95% CI 1.01–2.06). Higher Charlson Comorbidity Index, higher modified Acute Physiology and Chronic Health Evaluation score, and no targeted PA-BSI treatment within 48 h were also predictors of higher mortality. Conclusions: Higher mortality was observed in patients with COVID-19 coinfection among patients with PA-BSI. Future studies should explore this relationship in other settings and investigate potential SARS-CoV-2 and PA synergy. https://www.cambridge.org/core/product/identifier/S2732494X23004552/type/journal_article |
spellingShingle | Leila S. Hojat Brigid M. Wilson Federico Perez Maria F. Mojica Mendel E. Singer Robert A. Bonomo Lauren H. Epstein Association of COVID-19 coinfection with increased mortality among patients with Pseudomonas aeruginosa bloodstream infection in the Veterans Health Administration system Antimicrobial Stewardship & Healthcare Epidemiology |
title | Association of COVID-19 coinfection with increased mortality among patients with Pseudomonas aeruginosa bloodstream infection in the Veterans Health Administration system |
title_full | Association of COVID-19 coinfection with increased mortality among patients with Pseudomonas aeruginosa bloodstream infection in the Veterans Health Administration system |
title_fullStr | Association of COVID-19 coinfection with increased mortality among patients with Pseudomonas aeruginosa bloodstream infection in the Veterans Health Administration system |
title_full_unstemmed | Association of COVID-19 coinfection with increased mortality among patients with Pseudomonas aeruginosa bloodstream infection in the Veterans Health Administration system |
title_short | Association of COVID-19 coinfection with increased mortality among patients with Pseudomonas aeruginosa bloodstream infection in the Veterans Health Administration system |
title_sort | association of covid 19 coinfection with increased mortality among patients with pseudomonas aeruginosa bloodstream infection in the veterans health administration system |
url | https://www.cambridge.org/core/product/identifier/S2732494X23004552/type/journal_article |
work_keys_str_mv | AT leilashojat associationofcovid19coinfectionwithincreasedmortalityamongpatientswithpseudomonasaeruginosabloodstreaminfectionintheveteranshealthadministrationsystem AT brigidmwilson associationofcovid19coinfectionwithincreasedmortalityamongpatientswithpseudomonasaeruginosabloodstreaminfectionintheveteranshealthadministrationsystem AT federicoperez associationofcovid19coinfectionwithincreasedmortalityamongpatientswithpseudomonasaeruginosabloodstreaminfectionintheveteranshealthadministrationsystem AT mariafmojica associationofcovid19coinfectionwithincreasedmortalityamongpatientswithpseudomonasaeruginosabloodstreaminfectionintheveteranshealthadministrationsystem AT mendelesinger associationofcovid19coinfectionwithincreasedmortalityamongpatientswithpseudomonasaeruginosabloodstreaminfectionintheveteranshealthadministrationsystem AT robertabonomo associationofcovid19coinfectionwithincreasedmortalityamongpatientswithpseudomonasaeruginosabloodstreaminfectionintheveteranshealthadministrationsystem AT laurenhepstein associationofcovid19coinfectionwithincreasedmortalityamongpatientswithpseudomonasaeruginosabloodstreaminfectionintheveteranshealthadministrationsystem |